Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Clinical Trials Related to Solid Tumor
Related studies linked through entity extraction aliases.
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus
- Status
- COMPLETED
- Phase
- N/A
A Study of TBI-1401(HF10) in Patients With Solid Tumors With Superficial Lesions
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Dose-Escalation Study of OBP-801 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy
- Status
- COMPLETED
- Phase
- PHASE1
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety Study of Vx006 Vaccine in Solid Tumor Patients
- Status
- COMPLETED
- Phase
- PHASE1
Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Indocyanine Green for Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
First in Human Study of M4344 in Participants With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic Study of Docetaxel-PNP and Taxotere to Treat Patient With Advanced Solid Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or Angioimmunoblastic T-cell Lymphoma, With an IDH2 Mutation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study: Pure CBD as Single-agent for Solid Tumor.
- Status
- UNKNOWN
- Phase
- PHASE2
Safety and Biomarker of OPB-111077 in Subjects With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
A Dose-regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1